These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 20941510

  • 1. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
    Tachi K, Takami M, Zhao B, Mochizuki A, Yamada A, Miyamoto Y, Inoue T, Baba K, Kamijo R.
    Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
    [Abstract] [Full Text] [Related]

  • 2. Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-kappaB ligand expression in osteoblasts.
    Takami M, Mochizuki A, Yamada A, Tachi K, Zhao B, Miyamoto Y, Anada T, Honda Y, Inoue T, Nakamura M, Suzuki O, Kamijo R.
    Tissue Eng Part A; 2009 Dec; 15(12):3991-4000. PubMed ID: 19594360
    [Abstract] [Full Text] [Related]

  • 3. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
    Inada M, Tsukamoto K, Hirata M, Takita M, Nagasawa K, Miyaura C.
    Biochem Biophys Res Commun; 2008 Aug 01; 372(3):434-9. PubMed ID: 18489902
    [Abstract] [Full Text] [Related]

  • 4. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X, Wu J, Shidoji Y, Muto Y, Ohishi N, Yagi K, Ikegami S, Shinki T, Udagawa N, Suda T, Ishimi Y.
    J Bone Miner Res; 2002 Jan 01; 17(1):91-100. PubMed ID: 11771673
    [Abstract] [Full Text] [Related]

  • 5. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.
    J Bone Miner Res; 2004 Nov 01; 19(11):1873-81. PubMed ID: 15476588
    [Abstract] [Full Text] [Related]

  • 6. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.
    J Bone Miner Res; 2000 Sep 01; 15(9):1766-75. PubMed ID: 10976996
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
    Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G.
    J Clin Invest; 2006 Dec 01; 116(12):3150-9. PubMed ID: 17099775
    [Abstract] [Full Text] [Related]

  • 16. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
    Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K.
    J Bone Miner Res; 1995 Nov 01; 10(11):1681-90. PubMed ID: 8592944
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M, Murai J, Yoshikawa H, Tsumaki N.
    J Bone Miner Res; 2006 Jul 01; 21(7):1022-33. PubMed ID: 16813523
    [Abstract] [Full Text] [Related]

  • 19. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K.
    J Clin Invest; 2006 Feb 01; 116(2):528-35. PubMed ID: 16424941
    [Abstract] [Full Text] [Related]

  • 20. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation.
    Smith R, Ransjö M, Tatarczuch L, Song SJ, Pagel C, Morrison JR, Pike RN, Mackie EJ.
    J Bone Miner Res; 2004 Mar 01; 19(3):507-16. PubMed ID: 15040840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.